# Plain Language Summary: Block, Report, And Suspend Suspicious Shipments Act of 2021

This bill gives law enforcement and customs officials new tools to stop packages and shipments that look suspicious before they reach their destination. Specifically, it allows authorities to temporarily hold shipments they believe might contain illegal drugs, counterfeit goods, or other contraband while they investigate. Instead of having to let packages through or seize them permanently right away, officials can now pause shipments for a set period to gather more information and determine what's actually inside.

The bill creates a reporting system where law enforcement agencies share information about suspicious shipments with each other and with customs officials. This helps different agencies—whether it's the DEA, FBI, or local police—coordinate their efforts and spot patterns of illegal activity. For example, if multiple packages from the same sender are flagged as suspicious in different cities, authorities can now more easily connect those dots and potentially catch a larger smuggling operation.

For everyday people, this mainly affects anyone who ships or receives packages, particularly internationally. The bill could mean your package takes longer to arrive if it gets flagged for inspection, though authorities are supposed to work quickly. The law is designed to catch criminals trying to move drugs and counterfeit products through the mail system, so legitimate shippers shouldn't face major problems unless their packages genuinely look suspicious. The bill also includes protections to prevent abuse, requiring that any suspension of a shipment be based on reasonable suspicion of criminal activity rather than random targeting.

Block, Report, And Suspend Suspicious Shipments Act of 2021

McKinley, David B.

Block, Report, And Suspend Suspicious Shipments Act of 2021 This bill creates additional requirements for drug manufacturers and distributors who discover a suspicious order for controlled substances. In addition to reporting the suspicious order to the Drug Enforcement Administration (DEA), a manufacturer or distributor must also exercise due diligence and decline to fill the order. The DEA must issue regulations specifying the indicators that give rise to a suspicious order.